ME and Ophelia
Wednesday, May 19, 2004
- - -
BLOGGING PROTECTS AGAINST ALZHEIMER'S :-)
Use it or lose it
Courtesy of the Lancet Neurology June 2004 issue: Does doing the crossword every day protect against dementia? Or are those of us who don't participate in such cerebral activities already in the early stages of cognitive decline? Laura Fratiglioni and co-authors systematically analyse the published longitudinal studies exploring the effects of social network, physical activity, and non-physical leisure on cognition and dementia. They conclude that an active and socially integrated lifestyle in late life seems to protect against dementia and Alzheimer's disease.
- - -
ORAL SIMVASTATIN AND MS
Could it help ME?
Courtesy of the Lancet Neurology June 2004 issue: Statins and MS Drug treatments for multiple sclerosis (MS) are expensive and only partially effective. Recent knowledge that statins promote an anti-inflammatory response from the immune system suggest a potential in the treatment of MS. Timothy Vollmer and colleagues report that a daily dose of oral simvastatin over a 6-month period could inhibit the inflammatory components of MS that lead to neurological disability.
BLOGGING PROTECTS AGAINST ALZHEIMER'S :-)
Use it or lose it
Courtesy of the Lancet Neurology June 2004 issue: Does doing the crossword every day protect against dementia? Or are those of us who don't participate in such cerebral activities already in the early stages of cognitive decline? Laura Fratiglioni and co-authors systematically analyse the published longitudinal studies exploring the effects of social network, physical activity, and non-physical leisure on cognition and dementia. They conclude that an active and socially integrated lifestyle in late life seems to protect against dementia and Alzheimer's disease.
- - -
ORAL SIMVASTATIN AND MS
Could it help ME?
Courtesy of the Lancet Neurology June 2004 issue: Statins and MS Drug treatments for multiple sclerosis (MS) are expensive and only partially effective. Recent knowledge that statins promote an anti-inflammatory response from the immune system suggest a potential in the treatment of MS. Timothy Vollmer and colleagues report that a daily dose of oral simvastatin over a 6-month period could inhibit the inflammatory components of MS that lead to neurological disability.